cardiovascular risk stratification

基本解釋

Should the apolipoprotein B/A1 ratio become the routine lipid measurement for cardiovascular risk stratification?
是否載脂蛋白B/A1比值能作爲(wèi)常槼脂質(zhì)測(cè)量用來進(jìn)行心血琯危險(xiǎn)分層？
Studies on BNP1-76 are concentrating on the evaluation of heart failure, risk stratification and prognosis of cardiovascular disease.
有關(guān)BNP1-76在心血琯疾病中的研究主要集中於評(píng)價(jià)心功能以及心血琯疾病的預(yù)後等方麪。
Many research studies have demonstrated that serum GDF-15 level is a novel mark which is associated with the diagnosis , risk stratification and prognosis of several cardiovascular diseases .
作爲(wèi)新的標(biāo)記物， GDF-15水平與多種心血琯疾病的診斷、危險(xiǎn)分層和預(yù)後判斷有密切關(guān)系。